EMA established the group in 2022 to help implement the Agency's extended mandate in addressing public health emergencies, in line with Regulation (EU) 2022/123. For more information, see Crisis preparedness and management.
These meetings complement other forums for EMA dialogue with industry, such as EMA's industry stakeholder platform meetings and bilateral meetings with industry associations representing specific sectors.
While the bilateral meetings focus on a high level exchange of views, the industry stakeholder platform meetings have a more operational approach, discussing aspects linked to medicines development support, the centralised procedure and pharmacovigilance. For more information, see:
Industry Standing Group members and experts nominated based on agenda topics attend ISG meetings.
Use the links below to view meeting agendas, summaries and any related presentations made available.